14/05/2026
Not one pathway. Not two. Three.
Retatrutide is being studied as a triple agonist peptide — GLP-1 + GIP + Glucagon — and the research numbers are hard to ignore. 17.5% average weight loss in 24 weeks. Faster than Semaglutide. Faster than Tirzepatide.
Swipe to see how it works, how it compares, and what a beginner protocol looks like. 👆
💬 DM RETATRUTIDE and we’ll help you figure out if it’s the right fit.
For educational purposes only. All protocols under physician supervision.